South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

It will also push ahead with plans to make innovative and modern healthcare within Asia’s reach, says its chief executive ...

The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...